Halozyme
HALO
357 hedge funds and large institutions have $5.22B invested in Halozyme in 2022 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 134 increasing their positions, 124 reducing their positions, and 52 closing their positions.
244% more call options, than puts
Call options by funds: $18.4M | Put options by funds: $5.35M
3.08% more ownership
Funds ownership: 93.03% → 96.11% (+3.1%)
8% more repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 124
4% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 52
3% less funds holding
Funds holding: 367 → 357 (-10)
8% less capital invested
Capital invested by funds: $5.65B → $5.22B (-$428M)
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
+$44.2M |
| 2 |
Millennium Management
New York
|
+$40M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$30.5M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$24.7M |
| 5 |
Lazard Asset Management
New York
|
+$21.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Swedbank
Stockholm,
Sweden
|
-$26.5M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$26.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.1M |
| 4 |
Two Sigma Investments
New York
|
-$20.5M |
| 5 |
TCM
Tran Capital Management
San Rafael,
California
|
-$17.1M |
HALO Hedge Fund Activity: Q3 2022 in Review
357 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q3 2022, worth a combined $5.22B — down 7.6% from $5.65B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of HALO and 50 opened new positions — a net loss of 2 holders — while 124 trimmed existing stakes and 134 added.
The largest buyer was Fidelity International, opening a new position worth an estimated $44.2M. The largest seller was Swedbank, cutting an estimated $26.5M.
- 357 institutional investors held Halozyme (HALO) as of Q3 2022, down from 367 in Q2 2022.
- Funds reported $5.22B of Halozyme stock for Q3 2022, down 7.6% quarter-over-quarter.
- 50 funds opened new Halozyme positions in Q3 2022 and 52 closed out, a net change of -2 holders.
- The largest Halozyme buyer in Q3 2022 was Fidelity International, an estimated $44.2M added.
- The largest Halozyme seller in Q3 2022 was Swedbank, an estimated $26.5M sold.
Based on aggregated 13F filings for Q3 2022.